Samples Request

Click here to download

The first and only once-daily amoxicillin1, 2

MOXATAG  1 Tablet Once-Daily 10 Days1

Clinical Information

Once-daily MOXATAG: efficacy versus penicillin VK1

In a randomized, double-blind, multicenter, non-inferiority trial with MOXATAG involving adult and pediatric patients (≥12 years of age)…

  MOXATAG 775 mg once-daily achieved efficacy similar to that seen with penicillin VK 250 mg 4 times daily for 10 days in patients with tonsillitis/pharyngitis secondary to S. pyogenes1

Bacterial eradication rates (per-protocol population)1

Bacteriologic eradication rates were assessed at a test-of-cure (TOC) visit (Days 14 to 18).

 In the per-protocol bacteriologic (PPb) population, MOXATAG achieved bacterial eradication rates of 85.0% vs 83.4% with penicillin VK; rate difference 95% CI (%): 1.6 (-5.1, 8.2)1

  The per-protocol population included modified intent-to treat (mITT) patients who had post-therapy cultures, were compliant with treatment, and did not have major protocol violations

References: 1. MOXATAG [package insert]. Berwyn, PA: Vernalis Therapeutics, Inc; 2016. 2. Orange Book: Approved drug products with therapeutic equivalence evaluations. US Food and Drug Administration website. http://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm. Accessed August 2, 2017.

Contact Us

1-88VERNALIS (1-888-376-2547)